What We Do

BlueCloud® by HealthCarePoint is a private networking technology that seamlessly connects healthcare and clinical research industry stakeholders, enabling them to create unique, private business applications that improve patient care, expedite communications, streamline standards and eliminate fraud and abuse.

The BlueCloud® universal network reaches more than 162 countries and is used by over 1,000,000 healthcare professionals including 45 Sponsors, 14 CROs, 8 IRBs, universities, sites and other healthcare and clinical research industry stakeholders. Dozens of BlueCloud applications empower users to organize, centralize, connect, share and deliver verifiable, on-demand information required for doing business as well as for compliance through a common, secure system. The BlueCloud Network is saving the industry time, money and ultimately, saving lives.

How We Give Back

ciscrp-logoThe Research Literacy Connections for Tomorrow’s Cures campaign is a collaboration between the Center for Information and Study on Clinical Research Participation (CISCRP) and BlueCloud® by HealthCarePoint, for which BlueCloud® will donate one dollar per connection made on its online networking platform for CISCRP, in support of education and outreach to students and their families about clinical research. Dollar raised from the campaign will directly support the development of CISCRP’s Medical Heroes: A Traveling Museum Exhibit, which will engage elementary through high school age children and their families in 12 U.S. cities with interactive and experimental learning about the clinical research process and the role that clinical trials play in advancing public health. To learn more about CISCRP or the Medical Heroes Travel Museum, please visit www.ciscrp.org. Your BlueCloud® connections will make a difference for tomorrow’s cures!

Used by Nearly 1,000,000 Healthcare and Clinical Research Professionals From More Than 60,000 Organizations

News & Developments

Collaborative Campaign between BlueCloud® by HealthCarePoint and CISCRP to Provide Funding to Raise Clinical Research Literacy for Students and their Families

BOSTON, June 22, 2016 (GLOBE NEWSWIRE) -- BlueCloud by HealthCarePoint announced today a campaign that will donate one dollar per clinical trial HCP connection made on its online networking platform to the Center for Information and Study on Clinical Research ...

HealthCarePoint Successfully Completes Global Testing on BlueCloud 2.0 Networking Technology

BlueCloud® 2.0 is enabling industry stakeholders to develop dozens of new business models that reduce costs while improving patient care. HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking-technology company founded by patient survivors, today announced that it has successfully completed ...

ACRES Announces Second Phase of Collaborative IT Platform to Support Clinical Research

The Alliance for Clinical Research Excellence and Safety (ACRES), the global public-interest collaboration building a comprehensive system to transform clinical research, today announced a major second step toward full implementation of a multi-stakeholder shared information technology platform. Technology solutions ...

HealthCarePoint BlueCloud® Renews its Global Impact Partnership with the Society for Clinical Research Sites

The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced the renewal of a two-year relationship with HealthCarePoint, creators of the BlueCloud® Network (nominated as one of ...

HealthCarePoint BlueCloud Enhances Collaborations Between Institutional Review Boards and Investigators to Help Site Sustainability

Independent institutional review boards to connect with investigator sites, share and exchange verifiable healthcare professionals’ information and minimize redundancies. HealthCarePoint (HCP) today announced its collaboration with independent institutional review boards (IRBs). The announcement follows a meeting held at the 2015 Drug ...